Mistletoe Could Fight Obesity-Related Liver Disease

Mistletoe hanging in doorways announces that the holidays are approaching soon.

For some people, however, the symbolic plant might one day represent more than a kiss at Christmas time: It may mean better liver health. Researchers have found that a compound produced by a particular variety of the plant can help fight obesity-related liver disease in mice. Their study appears in ACS' Journal of Agricultural and Food Chemistry.

Gut Microflora Influences the Development of Nonalcoholic Fatty Liver Disease
New study provides a link between molecular signaling pathways in the gut, the intestinal microbiome, and development of NAFLD.

Jungkee Kwon and colleagues note that, according to recent research, Korean mistletoe produces a number of biologically active compounds. These include familiar ones such as steroids and flavonoids. Also, extracts from the plant have shown anti-obesity effects, but no one had confirmed which specific molecules were involved. Kwon's team wanted to investigate the matter and see if the key ingredient could also help fight fatty liver disease, which is associated with obesity and can progress to liver failure in some cases.

The researchers identified viscothionin as the compound in Korean mistletoe that affects fat metabolism in the liver. When they treated obese mice with it, their body and liver weights dropped. The scientists conclude that viscothionin could be explored as a potential therapeutic agent for the treatment of nonalcoholic fatty liver disease.

Source-Eurekalert

Call for an End to UK Postcode Lottery for Liver Disease Detection and Treatment
Liver disease is the UK's third commonest cause of premature death and medical experts warn Thursday that rising numbers of deaths from the cannot be avoided without improvements in treatment.

Obese Children With Nonalcoholic Fatty Liver Disease at Greater Risk of High Blood Pressure
Researchers have found obese children suffering from nonalcoholic fatty liver disease (NAFLD) are at an increased risk of suffering from high blood pressure.

New Treatments for Liver Diseases Elaborated
Several diseases of the liver including serious conditions like cirrhosis and nonalcoholic fatty liver disease (NAFLD) have limited pharmacological treatments.